Back to search

Peptide record

TPDB40595

oligopeptide 2 Anticancer standard
4 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB40595
oligopeptide 2
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 4-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
AERQ
Physicochemical Analysis
C19H34N8O8
NDCGHILKMFPSTWYV
AREQ
502.53
6.97
1
1
1
-0
3.24
-2.425
25.00
Mammalian: 4.4 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
1
Residue Composition
number
1
A
1
R
0
N
0
D
0
C
1
E
1
Q
0
G
0
H
0
I
0
L
0
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 1 R: 1 N: 0 D: 0 C: 0 E: 1 Q: 1 G: 0 H: 0 I: 0 L: 0 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
4
C19H34N8O8
502.53
6.97
-0
3.24
-2.425
Free
L
Linear
Free
Anticancer
Sarcophyton glaucum
Evidence Records 1 records
Evidence 1 Activity

Activity

EC50
EC50 = 4.9 mmol/L
Anticancer
4.9 mm

Target

Cervical Cancer
HeLa
Cervix

Assay & Model

MTT assay
25 h

Source & Reference

CancerPPD 2.0
CancerPPD2
2019

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.